The Global Liquid Biopsy For Cancer Diagnostics Market Size was estimated at USD 3919.70 million in 2023 and is projected to reach USD 7904.06 million by 2029, exhibiting a CAGR of 12.40% during the forecast period.
The USA market for Global Liquid Biopsy For Cancer Diagnostics market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The China market for Global Liquid Biopsy For Cancer Diagnostics market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The Europe market for Global Liquid Biopsy For Cancer Diagnostics market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
Report Overview:
Liquid biopsy for cancer diagnostics refers to a non-invasive medical test that analyzes blood or other body fluids to detect and analyze genetic alterations, proteins, or other molecules associated with cancer. Unlike traditional biopsies, which involve the surgical removal of a tissue sample, liquid biopsies provide a less invasive and more accessible method for detecting and monitoring cancer.
This report provides a deep insight into the global Liquid Biopsy For Cancer Diagnostics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porters five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Liquid Biopsy For Cancer Diagnostics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Liquid Biopsy For Cancer Diagnostics market in any manner.
Global Liquid Biopsy For Cancer Diagnostics Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
- F. Hoffman La Roche Ltd.
- Thermo Fisher Scientific Inc.
- Agilent Technologies Inc.
- Illumina Inc.
- The Menarini Group
- Bio-Rad Laboratories Inc.
- QIAGEN Inc.
- Exact Sciences Corporation
- Bio-Techne Corporation
- ArcherDX Inc.
- Neogenomics Laboratories Inc.
- Guardant Health Inc.
- Myriad Genetics Inc.
- Foundation Medicine Inc.
- Amoy Diagnostics Co. Ltd.
- Biocartis Group NV
Market Segmentation (by Type)
- Blood Test
- Urine Test
- Saliva Test
Market Segmentation (by Application)
- Hospital
- Diagnostic Center
- Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Liquid Biopsy For Cancer Diagnostics Market
- Overview of the regional outlook of the Liquid Biopsy For Cancer Diagnostics Market:
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porters five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Liquid Biopsy For Cancer Diagnostics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Liquid Biopsy For Cancer Diagnostics
1.2 Key Market Segments
1.2.1 Liquid Biopsy For Cancer Diagnostics Segment by Type
1.2.2 Liquid Biopsy For Cancer Diagnostics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Liquid Biopsy For Cancer Diagnostics Market Overview
2.1 Global Market Overview
2.1.1 Global Liquid Biopsy For Cancer Diagnostics Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Liquid Biopsy For Cancer Diagnostics Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Liquid Biopsy For Cancer Diagnostics Market Competitive Landscape
3.1 Global Liquid Biopsy For Cancer Diagnostics Sales by Manufacturers (2019-2024)
3.2 Global Liquid Biopsy For Cancer Diagnostics Revenue Market Share by Manufacturers (2019-2024)
3.3 Liquid Biopsy For Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Liquid Biopsy For Cancer Diagnostics Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Liquid Biopsy For Cancer Diagnostics Sales Sites, Area Served, Product Type
3.6 Liquid Biopsy For Cancer Diagnostics Market Competitive Situation and Trends
3.6.1 Liquid Biopsy For Cancer Diagnostics Market Concentration Rate
3.6.2 Global 5 and 10 Largest Liquid Biopsy For Cancer Diagnostics Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Liquid Biopsy For Cancer Diagnostics Industry Chain Analysis
4.1 Liquid Biopsy For Cancer Diagnostics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Liquid Biopsy For Cancer Diagnostics Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Liquid Biopsy For Cancer Diagnostics Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Liquid Biopsy For Cancer Diagnostics Sales Market Share by Type (2019-2024)
6.3 Global Liquid Biopsy For Cancer Diagnostics Market Size Market Share by Type (2019-2024)
6.4 Global Liquid Biopsy For Cancer Diagnostics Price by Type (2019-2024)
7 Liquid Biopsy For Cancer Diagnostics Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Liquid Biopsy For Cancer Diagnostics Market Sales by Application (2019-2024)
7.3 Global Liquid Biopsy For Cancer Diagnostics Market Size (M USD) by Application (2019-2024)
7.4 Global Liquid Biopsy For Cancer Diagnostics Sales Growth Rate by Application (2019-2024)
8 Liquid Biopsy For Cancer Diagnostics Market Segmentation by Region
8.1 Global Liquid Biopsy For Cancer Diagnostics Sales by Region
8.1.1 Global Liquid Biopsy For Cancer Diagnostics Sales by Region
8.1.2 Global Liquid Biopsy For Cancer Diagnostics Sales Market Share by Region
8.2 North America
8.2.1 North America Liquid Biopsy For Cancer Diagnostics Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Liquid Biopsy For Cancer Diagnostics Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Liquid Biopsy For Cancer Diagnostics Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Liquid Biopsy For Cancer Diagnostics Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Liquid Biopsy For Cancer Diagnostics Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 F. Hoffman La Roche Ltd.
9.1.1 F. Hoffman La Roche Ltd. Liquid Biopsy For Cancer Diagnostics Basic Information
9.1.2 F. Hoffman La Roche Ltd. Liquid Biopsy For Cancer Diagnostics Product Overview
9.1.3 F. Hoffman La Roche Ltd. Liquid Biopsy For Cancer Diagnostics Product Market Performance
9.1.4 F. Hoffman La Roche Ltd. Business Overview
9.1.5 F. Hoffman La Roche Ltd. Liquid Biopsy For Cancer Diagnostics SWOT Analysis
9.1.6 F. Hoffman La Roche Ltd. Recent Developments
9.2 Thermo Fisher Scientific Inc.
9.2.1 Thermo Fisher Scientific Inc. Liquid Biopsy For Cancer Diagnostics Basic Information
9.2.2 Thermo Fisher Scientific Inc. Liquid Biopsy For Cancer Diagnostics Product Overview
9.2.3 Thermo Fisher Scientific Inc. Liquid Biopsy For Cancer Diagnostics Product Market Performance
9.2.4 Thermo Fisher Scientific Inc. Business Overview
9.2.5 Thermo Fisher Scientific Inc. Liquid Biopsy For Cancer Diagnostics SWOT Analysis
9.2.6 Thermo Fisher Scientific Inc. Recent Developments
9.3 Agilent Technologies Inc.
9.3.1 Agilent Technologies Inc. Liquid Biopsy For Cancer Diagnostics Basic Information
9.3.2 Agilent Technologies Inc. Liquid Biopsy For Cancer Diagnostics Product Overview
9.3.3 Agilent Technologies Inc. Liquid Biopsy For Cancer Diagnostics Product Market Performance
9.3.4 Agilent Technologies Inc. Liquid Biopsy For Cancer Diagnostics SWOT Analysis
9.3.5 Agilent Technologies Inc. Business Overview
9.3.6 Agilent Technologies Inc. Recent Developments
9.4 Illumina Inc.
9.4.1 Illumina Inc. Liquid Biopsy For Cancer Diagnostics Basic Information
9.4.2 Illumina Inc. Liquid Biopsy For Cancer Diagnostics Product Overview
9.4.3 Illumina Inc. Liquid Biopsy For Cancer Diagnostics Product Market Performance
9.4.4 Illumina Inc. Business Overview
9.4.5 Illumina Inc. Recent Developments
9.5 The Menarini Group
9.5.1 The Menarini Group Liquid Biopsy For Cancer Diagnostics Basic Information
9.5.2 The Menarini Group Liquid Biopsy For Cancer Diagnostics Product Overview
9.5.3 The Menarini Group Liquid Biopsy For Cancer Diagnostics Product Market Performance
9.5.4 The Menarini Group Business Overview
9.5.5 The Menarini Group Recent Developments
9.6 Bio-Rad Laboratories Inc.
9.6.1 Bio-Rad Laboratories Inc. Liquid Biopsy For Cancer Diagnostics Basic Information
9.6.2 Bio-Rad Laboratories Inc. Liquid Biopsy For Cancer Diagnostics Product Overview
9.6.3 Bio-Rad Laboratories Inc. Liquid Biopsy For Cancer Diagnostics Product Market Performance
9.6.4 Bio-Rad Laboratories Inc. Business Overview
9.6.5 Bio-Rad Laboratories Inc. Recent Developments
9.7 QIAGEN Inc.
9.7.1 QIAGEN Inc. Liquid Biopsy For Cancer Diagnostics Basic Information
9.7.2 QIAGEN Inc. Liquid Biopsy For Cancer Diagnostics Product Overview
9.7.3 QIAGEN Inc. Liquid Biopsy For Cancer Diagnostics Product Market Performance
9.7.4 QIAGEN Inc. Business Overview
9.7.5 QIAGEN Inc. Recent Developments
9.8 Exact Sciences Corporation
9.8.1 Exact Sciences Corporation Liquid Biopsy For Cancer Diagnostics Basic Information
9.8.2 Exact Sciences Corporation Liquid Biopsy For Cancer Diagnostics Product Overview
9.8.3 Exact Sciences Corporation Liquid Biopsy For Cancer Diagnostics Product Market Performance
9.8.4 Exact Sciences Corporation Business Overview
9.8.5 Exact Sciences Corporation Recent Developments
9.9 Bio-Techne Corporation
9.9.1 Bio-Techne Corporation Liquid Biopsy For Cancer Diagnostics Basic Information
9.9.2 Bio-Techne Corporation Liquid Biopsy For Cancer Diagnostics Product Overview
9.9.3 Bio-Techne Corporation Liquid Biopsy For Cancer Diagnostics Product Market Performance
9.9.4 Bio-Techne Corporation Business Overview
9.9.5 Bio-Techne Corporation Recent Developments
9.10 ArcherDX Inc.
9.10.1 ArcherDX Inc. Liquid Biopsy For Cancer Diagnostics Basic Information
9.10.2 ArcherDX Inc. Liquid Biopsy For Cancer Diagnostics Product Overview
9.10.3 ArcherDX Inc. Liquid Biopsy For Cancer Diagnostics Product Market Performance
9.10.4 ArcherDX Inc. Business Overview
9.10.5 ArcherDX Inc. Recent Developments
9.11 Neogenomics Laboratories Inc.
9.11.1 Neogenomics Laboratories Inc. Liquid Biopsy For Cancer Diagnostics Basic Information
9.11.2 Neogenomics Laboratories Inc. Liquid Biopsy For Cancer Diagnostics Product Overview
9.11.3 Neogenomics Laboratories Inc. Liquid Biopsy For Cancer Diagnostics Product Market Performance
9.11.4 Neogenomics Laboratories Inc. Business Overview
9.11.5 Neogenomics Laboratories Inc. Recent Developments
9.12 Guardant Health Inc.
9.12.1 Guardant Health Inc. Liquid Biopsy For Cancer Diagnostics Basic Information
9.12.2 Guardant Health Inc. Liquid Biopsy For Cancer Diagnostics Product Overview
9.12.3 Guardant Health Inc. Liquid Biopsy For Cancer Diagnostics Product Market Performance
9.12.4 Guardant Health Inc. Business Overview
9.12.5 Guardant Health Inc. Recent Developments
9.13 Myriad Genetics Inc.
9.13.1 Myriad Genetics Inc. Liquid Biopsy For Cancer Diagnostics Basic Information
9.13.2 Myriad Genetics Inc. Liquid Biopsy For Cancer Diagnostics Product Overview
9.13.3 Myriad Genetics Inc. Liquid Biopsy For Cancer Diagnostics Product Market Performance
9.13.4 Myriad Genetics Inc. Business Overview
9.13.5 Myriad Genetics Inc. Recent Developments
9.14 Foundation Medicine Inc.
9.14.1 Foundation Medicine Inc. Liquid Biopsy For Cancer Diagnostics Basic Information
9.14.2 Foundation Medicine Inc. Liquid Biopsy For Cancer Diagnostics Product Overview
9.14.3 Foundation Medicine Inc. Liquid Biopsy For Cancer Diagnostics Product Market Performance
9.14.4 Foundation Medicine Inc. Business Overview
9.14.5 Foundation Medicine Inc. Recent Developments
9.15 Amoy Diagnostics Co. Ltd.
9.15.1 Amoy Diagnostics Co. Ltd. Liquid Biopsy For Cancer Diagnostics Basic Information
9.15.2 Amoy Diagnostics Co. Ltd. Liquid Biopsy For Cancer Diagnostics Product Overview
9.15.3 Amoy Diagnostics Co. Ltd. Liquid Biopsy For Cancer Diagnostics Product Market Performance
9.15.4 Amoy Diagnostics Co. Ltd. Business Overview
9.15.5 Amoy Diagnostics Co. Ltd. Recent Developments
9.16 Biocartis Group NV
9.16.1 Biocartis Group NV Liquid Biopsy For Cancer Diagnostics Basic Information
9.16.2 Biocartis Group NV Liquid Biopsy For Cancer Diagnostics Product Overview
9.16.3 Biocartis Group NV Liquid Biopsy For Cancer Diagnostics Product Market Performance
9.16.4 Biocartis Group NV Business Overview
9.16.5 Biocartis Group NV Recent Developments
10 Liquid Biopsy For Cancer Diagnostics Market Forecast by Region
10.1 Global Liquid Biopsy For Cancer Diagnostics Market Size Forecast
10.2 Global Liquid Biopsy For Cancer Diagnostics Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Liquid Biopsy For Cancer Diagnostics Market Size Forecast by Country
10.2.3 Asia Pacific Liquid Biopsy For Cancer Diagnostics Market Size Forecast by Region
10.2.4 South America Liquid Biopsy For Cancer Diagnostics Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Liquid Biopsy For Cancer Diagnostics by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Liquid Biopsy For Cancer Diagnostics Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Liquid Biopsy For Cancer Diagnostics by Type (2025-2030)
11.1.2 Global Liquid Biopsy For Cancer Diagnostics Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Liquid Biopsy For Cancer Diagnostics by Type (2025-2030)
11.2 Global Liquid Biopsy For Cancer Diagnostics Market Forecast by Application (2025-2030)
11.2.1 Global Liquid Biopsy For Cancer Diagnostics Sales (K Units) Forecast by Application
11.2.2 Global Liquid Biopsy For Cancer Diagnostics Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Liquid Biopsy For Cancer Diagnostics Market Size Comparison by Region (M USD)
Table 5. Global Liquid Biopsy For Cancer Diagnostics Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Liquid Biopsy For Cancer Diagnostics Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Liquid Biopsy For Cancer Diagnostics Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Liquid Biopsy For Cancer Diagnostics Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liquid Biopsy For Cancer Diagnostics as of 2022)
Table 10. Global Market Liquid Biopsy For Cancer Diagnostics Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Liquid Biopsy For Cancer Diagnostics Sales Sites and Area Served
Table 12. Manufacturers Liquid Biopsy For Cancer Diagnostics Product Type
Table 13. Global Liquid Biopsy For Cancer Diagnostics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Liquid Biopsy For Cancer Diagnostics
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Liquid Biopsy For Cancer Diagnostics Market Challenges
Table 22. Global Liquid Biopsy For Cancer Diagnostics Sales by Type (K Units)
Table 23. Global Liquid Biopsy For Cancer Diagnostics Market Size by Type (M USD)
Table 24. Global Liquid Biopsy For Cancer Diagnostics Sales (K Units) by Type (2019-2024)
Table 25. Global Liquid Biopsy For Cancer Diagnostics Sales Market Share by Type (2019-2024)
Table 26. Global Liquid Biopsy For Cancer Diagnostics Market Size (M USD) by Type (2019-2024)
Table 27. Global Liquid Biopsy For Cancer Diagnostics Market Size Share by Type (2019-2024)
Table 28. Global Liquid Biopsy For Cancer Diagnostics Price (USD/Unit) by Type (2019-2024)
Table 29. Global Liquid Biopsy For Cancer Diagnostics Sales (K Units) by Application
Table 30. Global Liquid Biopsy For Cancer Diagnostics Market Size by Application
Table 31. Global Liquid Biopsy For Cancer Diagnostics Sales by Application (2019-2024) & (K Units)
Table 32. Global Liquid Biopsy For Cancer Diagnostics Sales Market Share by Application (2019-2024)
Table 33. Global Liquid Biopsy For Cancer Diagnostics Sales by Application (2019-2024) & (M USD)
Table 34. Global Liquid Biopsy For Cancer Diagnostics Market Share by Application (2019-2024)
Table 35. Global Liquid Biopsy For Cancer Diagnostics Sales Growth Rate by Application (2019-2024)
Table 36. Global Liquid Biopsy For Cancer Diagnostics Sales by Region (2019-2024) & (K Units)
Table 37. Global Liquid Biopsy For Cancer Diagnostics Sales Market Share by Region (2019-2024)
Table 38. North America Liquid Biopsy For Cancer Diagnostics Sales by Country (2019-2024) & (K Units)
Table 39. Europe Liquid Biopsy For Cancer Diagnostics Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Liquid Biopsy For Cancer Diagnostics Sales by Region (2019-2024) & (K Units)
Table 41. South America Liquid Biopsy For Cancer Diagnostics Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Liquid Biopsy For Cancer Diagnostics Sales by Region (2019-2024) & (K Units)
Table 43. F. Hoffman La Roche Ltd. Liquid Biopsy For Cancer Diagnostics Basic Information
Table 44. F. Hoffman La Roche Ltd. Liquid Biopsy For Cancer Diagnostics Product Overview
Table 45. F. Hoffman La Roche Ltd. Liquid Biopsy For Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. F. Hoffman La Roche Ltd. Business Overview
Table 47. F. Hoffman La Roche Ltd. Liquid Biopsy For Cancer Diagnostics SWOT Analysis
Table 48. F. Hoffman La Roche Ltd. Recent Developments
Table 49. Thermo Fisher Scientific Inc. Liquid Biopsy For Cancer Diagnostics Basic Information
Table 50. Thermo Fisher Scientific Inc. Liquid Biopsy For Cancer Diagnostics Product Overview
Table 51. Thermo Fisher Scientific Inc. Liquid Biopsy For Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Thermo Fisher Scientific Inc. Business Overview
Table 53. Thermo Fisher Scientific Inc. Liquid Biopsy For Cancer Diagnostics SWOT Analysis
Table 54. Thermo Fisher Scientific Inc. Recent Developments
Table 55. Agilent Technologies Inc. Liquid Biopsy For Cancer Diagnostics Basic Information
Table 56. Agilent Technologies Inc. Liquid Biopsy For Cancer Diagnostics Product Overview
Table 57. Agilent Technologies Inc. Liquid Biopsy For Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Agilent Technologies Inc. Liquid Biopsy For Cancer Diagnostics SWOT Analysis
Table 59. Agilent Technologies Inc. Business Overview
Table 60. Agilent Technologies Inc. Recent Developments
Table 61. Illumina Inc. Liquid Biopsy For Cancer Diagnostics Basic Information
Table 62. Illumina Inc. Liquid Biopsy For Cancer Diagnostics Product Overview
Table 63. Illumina Inc. Liquid Biopsy For Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Illumina Inc. Business Overview
Table 65. Illumina Inc. Recent Developments
Table 66. The Menarini Group Liquid Biopsy For Cancer Diagnostics Basic Information
Table 67. The Menarini Group Liquid Biopsy For Cancer Diagnostics Product Overview
Table 68. The Menarini Group Liquid Biopsy For Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. The Menarini Group Business Overview
Table 70. The Menarini Group Recent Developments
Table 71. Bio-Rad Laboratories Inc. Liquid Biopsy For Cancer Diagnostics Basic Information
Table 72. Bio-Rad Laboratories Inc. Liquid Biopsy For Cancer Diagnostics Product Overview
Table 73. Bio-Rad Laboratories Inc. Liquid Biopsy For Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Bio-Rad Laboratories Inc. Business Overview
Table 75. Bio-Rad Laboratories Inc. Recent Developments
Table 76. QIAGEN Inc. Liquid Biopsy For Cancer Diagnostics Basic Information
Table 77. QIAGEN Inc. Liquid Biopsy For Cancer Diagnostics Product Overview
Table 78. QIAGEN Inc. Liquid Biopsy For Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. QIAGEN Inc. Business Overview
Table 80. QIAGEN Inc. Recent Developments
Table 81. Exact Sciences Corporation Liquid Biopsy For Cancer Diagnostics Basic Information
Table 82. Exact Sciences Corporation Liquid Biopsy For Cancer Diagnostics Product Overview
Table 83. Exact Sciences Corporation Liquid Biopsy For Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Exact Sciences Corporation Business Overview
Table 85. Exact Sciences Corporation Recent Developments
Table 86. Bio-Techne Corporation Liquid Biopsy For Cancer Diagnostics Basic Information
Table 87. Bio-Techne Corporation Liquid Biopsy For Cancer Diagnostics Product Overview
Table 88. Bio-Techne Corporation Liquid Biopsy For Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Bio-Techne Corporation Business Overview
Table 90. Bio-Techne Corporation Recent Developments
Table 91. ArcherDX Inc. Liquid Biopsy For Cancer Diagnostics Basic Information
Table 92. ArcherDX Inc. Liquid Biopsy For Cancer Diagnostics Product Overview
Table 93. ArcherDX Inc. Liquid Biopsy For Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. ArcherDX Inc. Business Overview
Table 95. ArcherDX Inc. Recent Developments
Table 96. Neogenomics Laboratories Inc. Liquid Biopsy For Cancer Diagnostics Basic Information
Table 97. Neogenomics Laboratories Inc. Liquid Biopsy For Cancer Diagnostics Product Overview
Table 98. Neogenomics Laboratories Inc. Liquid Biopsy For Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Neogenomics Laboratories Inc. Business Overview
Table 100. Neogenomics Laboratories Inc. Recent Developments
Table 101. Guardant Health Inc. Liquid Biopsy For Cancer Diagnostics Basic Information
Table 102. Guardant Health Inc. Liquid Biopsy For Cancer Diagnostics Product Overview
Table 103. Guardant Health Inc. Liquid Biopsy For Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Guardant Health Inc. Business Overview
Table 105. Guardant Health Inc. Recent Developments
Table 106. Myriad Genetics Inc. Liquid Biopsy For Cancer Diagnostics Basic Information
Table 107. Myriad Genetics Inc. Liquid Biopsy For Cancer Diagnostics Product Overview
Table 108. Myriad Genetics Inc. Liquid Biopsy For Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Myriad Genetics Inc. Business Overview
Table 110. Myriad Genetics Inc. Recent Developments
Table 111. Foundation Medicine Inc. Liquid Biopsy For Cancer Diagnostics Basic Information
Table 112. Foundation Medicine Inc. Liquid Biopsy For Cancer Diagnostics Product Overview
Table 113. Foundation Medicine Inc. Liquid Biopsy For Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. Foundation Medicine Inc. Business Overview
Table 115. Foundation Medicine Inc. Recent Developments
Table 116. Amoy Diagnostics Co. Ltd. Liquid Biopsy For Cancer Diagnostics Basic Information
Table 117. Amoy Diagnostics Co. Ltd. Liquid Biopsy For Cancer Diagnostics Product Overview
Table 118. Amoy Diagnostics Co. Ltd. Liquid Biopsy For Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. Amoy Diagnostics Co. Ltd. Business Overview
Table 120. Amoy Diagnostics Co. Ltd. Recent Developments
Table 121. Biocartis Group NV Liquid Biopsy For Cancer Diagnostics Basic Information
Table 122. Biocartis Group NV Liquid Biopsy For Cancer Diagnostics Product Overview
Table 123. Biocartis Group NV Liquid Biopsy For Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 124. Biocartis Group NV Business Overview
Table 125. Biocartis Group NV Recent Developments
Table 126. Global Liquid Biopsy For Cancer Diagnostics Sales Forecast by Region (2025-2030) & (K Units)
Table 127. Global Liquid Biopsy For Cancer Diagnostics Market Size Forecast by Region (2025-2030) & (M USD)
Table 128. North America Liquid Biopsy For Cancer Diagnostics Sales Forecast by Country (2025-2030) & (K Units)
Table 129. North America Liquid Biopsy For Cancer Diagnostics Market Size Forecast by Country (2025-2030) & (M USD)
Table 130. Europe Liquid Biopsy For Cancer Diagnostics Sales Forecast by Country (2025-2030) & (K Units)
Table 131. Europe Liquid Biopsy For Cancer Diagnostics Market Size Forecast by Country (2025-2030) & (M USD)
Table 132. Asia Pacific Liquid Biopsy For Cancer Diagnostics Sales Forecast by Region (2025-2030) & (K Units)
Table 133. Asia Pacific Liquid Biopsy For Cancer Diagnostics Market Size Forecast by Region (2025-2030) & (M USD)
Table 134. South America Liquid Biopsy For Cancer Diagnostics Sales Forecast by Country (2025-2030) & (K Units)
Table 135. South America Liquid Biopsy For Cancer Diagnostics Market Size Forecast by Country (2025-2030) & (M USD)
Table 136. Middle East and Africa Liquid Biopsy For Cancer Diagnostics Consumption Forecast by Country (2025-2030) & (Units)
Table 137. Middle East and Africa Liquid Biopsy For Cancer Diagnostics Market Size Forecast by Country (2025-2030) & (M USD)
Table 138. Global Liquid Biopsy For Cancer Diagnostics Sales Forecast by Type (2025-2030) & (K Units)
Table 139. Global Liquid Biopsy For Cancer Diagnostics Market Size Forecast by Type (2025-2030) & (M USD)
Table 140. Global Liquid Biopsy For Cancer Diagnostics Price Forecast by Type (2025-2030) & (USD/Unit)
Table 141. Global Liquid Biopsy For Cancer Diagnostics Sales (K Units) Forecast by Application (2025-2030)
Table 142. Global Liquid Biopsy For Cancer Diagnostics Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Liquid Biopsy For Cancer Diagnostics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Liquid Biopsy For Cancer Diagnostics Market Size (M USD), 2019-2030
Figure 5. Global Liquid Biopsy For Cancer Diagnostics Market Size (M USD) (2019-2030)
Figure 6. Global Liquid Biopsy For Cancer Diagnostics Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Liquid Biopsy For Cancer Diagnostics Market Size by Country (M USD)
Figure 11. Liquid Biopsy For Cancer Diagnostics Sales Share by Manufacturers in 2023
Figure 12. Global Liquid Biopsy For Cancer Diagnostics Revenue Share by Manufacturers in 2023
Figure 13. Liquid Biopsy For Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Liquid Biopsy For Cancer Diagnostics Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Liquid Biopsy For Cancer Diagnostics Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Liquid Biopsy For Cancer Diagnostics Market Share by Type
Figure 18. Sales Market Share of Liquid Biopsy For Cancer Diagnostics by Type (2019-2024)
Figure 19. Sales Market Share of Liquid Biopsy For Cancer Diagnostics by Type in 2023
Figure 20. Market Size Share of Liquid Biopsy For Cancer Diagnostics by Type (2019-2024)
Figure 21. Market Size Market Share of Liquid Biopsy For Cancer Diagnostics by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Liquid Biopsy For Cancer Diagnostics Market Share by Application
Figure 24. Global Liquid Biopsy For Cancer Diagnostics Sales Market Share by Application (2019-2024)
Figure 25. Global Liquid Biopsy For Cancer Diagnostics Sales Market Share by Application in 2023
Figure 26. Global Liquid Biopsy For Cancer Diagnostics Market Share by Application (2019-2024)
Figure 27. Global Liquid Biopsy For Cancer Diagnostics Market Share by Application in 2023
Figure 28. Global Liquid Biopsy For Cancer Diagnostics Sales Growth Rate by Application (2019-2024)
Figure 29. Global Liquid Biopsy For Cancer Diagnostics Sales Market Share by Region (2019-2024)
Figure 30. North America Liquid Biopsy For Cancer Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Liquid Biopsy For Cancer Diagnostics Sales Market Share by Country in 2023
Figure 32. U.S. Liquid Biopsy For Cancer Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Liquid Biopsy For Cancer Diagnostics Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Liquid Biopsy For Cancer Diagnostics Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Liquid Biopsy For Cancer Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Liquid Biopsy For Cancer Diagnostics Sales Market Share by Country in 2023
Figure 37. Germany Liquid Biopsy For Cancer Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Liquid Biopsy For Cancer Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Liquid Biopsy For Cancer Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Liquid Biopsy For Cancer Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Liquid Biopsy For Cancer Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Liquid Biopsy For Cancer Diagnostics Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Liquid Biopsy For Cancer Diagnostics Sales Market Share by Region in 2023
Figure 44. China Liquid Biopsy For Cancer Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Liquid Biopsy For Cancer Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Liquid Biopsy For Cancer Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Liquid Biopsy For Cancer Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Liquid Biopsy For Cancer Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Liquid Biopsy For Cancer Diagnostics Sales and Growth Rate (K Units)
Figure 50. South America Liquid Biopsy For Cancer Diagnostics Sales Market Share by Country in 2023
Figure 51. Brazil Liquid Biopsy For Cancer Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Liquid Biopsy For Cancer Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Liquid Biopsy For Cancer Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Liquid Biopsy For Cancer Diagnostics Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Liquid Biopsy For Cancer Diagnostics Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Liquid Biopsy For Cancer Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Liquid Biopsy For Cancer Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Liquid Biopsy For Cancer Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Liquid Biopsy For Cancer Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Liquid Biopsy For Cancer Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Liquid Biopsy For Cancer Diagnostics Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Liquid Biopsy For Cancer Diagnostics Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Liquid Biopsy For Cancer Diagnostics Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Liquid Biopsy For Cancer Diagnostics Market Share Forecast by Type (2025-2030)
Figure 65. Global Liquid Biopsy For Cancer Diagnostics Sales Forecast by Application (2025-2030)
Figure 66. Global Liquid Biopsy For Cancer Diagnostics Market Share Forecast by Application (2025-2030)
